The Advanced Therapies Congress UK 2026 is Europe’s largest and most crucial commercial gathering dedicated to the entire cell and gene therapy (CGT) ecosystem. This essential two-day event brings together a community of over 3,300 senior global executives, pioneering biotech and pharma leaders, academics, clinicians, and regulators. The mission is clear: to accelerate the development and commercialisation of next-generation Advanced Therapy Medicinal Products (ATMPs). Attendees will gain comprehensive, practical insights covering the full value chain. We tackle everything from the latest advancements in gene editing and allogeneic cell therapy development to critical operational hurdles in scalable manufacturing, viral vector production, and complex cold chain logistics. Furthermore, the congress features crucial strategic discussions on regulatory compliance, reimbursement models, and market access strategies required to successfully deliver these transformative, one-time treatments to patients.